Scholars Central

Conference abstractPublished 19 Sep 2018

Hypoxia-inducible factor-2a facilitates the expression of ZBP-89 and programmed cell death 4 in hepatocellular carcinoma

Authors: George G Chen

The Chinese University of Hong Kong, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The role of hypoxia-inducible factor-2 alpha (HIF-2a) in cancer is debatable, and its status in hepatocellular carcinoma (HCC) is poorly understood. ZBP-89 and programmed cell death 4 (PDCD4) are known to function as suppressors in HCC via stimulating apoptotic-related molecules but inhibiting some key molecules associated with hepatic cancer stem cells. The connection between HIF-2a and ZBP-89/PDCD4 remains elusive. In this study, we assessed the expression of HIF-2a in HCC samples and explored how HIF-2a impacted the levels of ZBP-89 and PDCD in HCC cells. Our results showed that the level of HIF-2a protein in HCC tumor tissues was significantly lower than in non-tumoral tissues. The high expression of HIF-2a in HCC cells was associated with a slower growth rate, whereas cells transfected with HIF-2a shRNA grew faster than the control. The HIF-2a-mediated reduction of the HCC growth was associated with the elevation of pro-apoptotic molecules ZBP-89 and PDCD4. By analysing ZBP-89 and PDCD4 genes, it was found that both ZBP-89 and PDCD4 promoters contained several potential HIF-2a binding sites. The luciferase assay showed that the promoter activities of ZBP-89 and PDCD4 could be significantly increased by HIF-2a overexpression whereas their activities were obviously decreased by blocking HIF-2a. Our data have also shown that ZBP-89 could negatively regulate hepatic cancer stem cells. PDCD4 is also known to restrain the self-renewal of stem cells. In conclusion, our data have demonstrated that the HCC is associated with downregulation of HIF- 2a, leading to decreasing the levels of ZBP-89 and PDCD4. The findings suggest that HIF-2a downregulation may facilitate the growth of HCC by reducing ZBP-89 and PDCD4 levels, subsequently inhibiting apoptosis in HCC cells but stimulating hepatic cancer stem cells. (This study was supported by grants from CUHK direct grant (4054308), the Research Grants Council of the Hong Kong Special Administrative Region (14109516) and the National Natural Science Foundation of China (81472339).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Signaling.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Signaling
  • SubjectGastroenterology & Hepatology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “George G Chen”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels